Oppenheimer & Co. Inc. lessened its holdings in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 24.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,715 shares of the technology company's stock after selling 3,443 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in AMETEK were worth $1,931,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Itau Unibanco Holding S.A. raised its position in AMETEK by 62.6% during the third quarter. Itau Unibanco Holding S.A. now owns 200 shares of the technology company's stock valued at $34,000 after purchasing an additional 77 shares in the last quarter. Versant Capital Management Inc lifted its position in AMETEK by 3,116.7% in the 4th quarter. Versant Capital Management Inc now owns 193 shares of the technology company's stock worth $35,000 after buying an additional 187 shares during the last quarter. AdvisorNet Financial Inc boosted its stake in AMETEK by 1,176.5% in the fourth quarter. AdvisorNet Financial Inc now owns 217 shares of the technology company's stock worth $39,000 after buying an additional 200 shares in the last quarter. Geneos Wealth Management Inc. grew its position in AMETEK by 42.9% during the fourth quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company's stock valued at $42,000 after acquiring an additional 70 shares during the last quarter. Finally, Princeton Global Asset Management LLC purchased a new position in shares of AMETEK during the third quarter worth approximately $44,000. Hedge funds and other institutional investors own 87.43% of the company's stock.
AMETEK Trading Down 0.0 %
NYSE AME traded down $0.03 during trading on Friday, hitting $184.12. The company had a trading volume of 1,624,437 shares, compared to its average volume of 1,353,961. The company's fifty day moving average is $183.34 and its 200-day moving average is $179.69. The company has a market cap of $42.47 billion, a price-to-earnings ratio of 31.05, a price-to-earnings-growth ratio of 2.73 and a beta of 1.14. The company has a current ratio of 1.24, a quick ratio of 0.75 and a debt-to-equity ratio of 0.15. AMETEK, Inc. has a one year low of $149.03 and a one year high of $198.33.
AMETEK (NYSE:AME - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.87 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.02. AMETEK had a return on equity of 16.94% and a net margin of 19.83%. The business had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.82 billion. During the same period in the previous year, the firm posted $1.68 EPS. The business's revenue was up 1.8% on a year-over-year basis. On average, sell-side analysts predict that AMETEK, Inc. will post 7.15 earnings per share for the current year.
AMETEK announced that its board has approved a share repurchase program on Friday, February 7th that permits the company to buyback $1.25 billion in outstanding shares. This buyback authorization permits the technology company to reacquire up to 2.9% of its stock through open market purchases. Stock buyback programs are often an indication that the company's management believes its shares are undervalued.
AMETEK Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Friday, March 14th will be issued a $0.31 dividend. This is a positive change from AMETEK's previous quarterly dividend of $0.28. The ex-dividend date is Friday, March 14th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.67%. AMETEK's dividend payout ratio (DPR) is presently 20.91%.
Insider Activity
In other AMETEK news, Director Steven W. Kohlhagen sold 1,320 shares of the business's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $189.41, for a total transaction of $250,021.20. Following the completion of the sale, the director now owns 22,029 shares of the company's stock, valued at approximately $4,172,512.89. The trade was a 5.65 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.61% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on AME shares. BNP Paribas raised shares of AMETEK from a "neutral" rating to an "outperform" rating and set a $210.00 target price on the stock in a report on Thursday, January 16th. KeyCorp raised their price objective on AMETEK from $205.00 to $215.00 and gave the company an "overweight" rating in a research note on Friday, November 22nd. Bank of America raised AMETEK from a "neutral" rating to a "buy" rating and boosted their target price for the company from $195.00 to $225.00 in a research note on Monday, December 16th. Truist Financial raised their price target on AMETEK from $221.00 to $222.00 and gave the stock a "buy" rating in a research report on Thursday, January 16th. Finally, StockNews.com downgraded AMETEK from a "buy" rating to a "hold" rating in a research report on Saturday, March 1st. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $204.67.
Get Our Latest Stock Report on AMETEK
AMETEK Profile
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
See Also

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report